Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter
NASDAQ| TSX: ACB
Achieves Record Annual Global Medical Cannabis Net Revenue 1 of $244.4 million, representing 39% YoY growth
Delivers Record Adjusted EBITDA 1 of $49.7 million, representing 261% YoY growth
Generates Annual Positive Free Cash Flow 1 of $9.9 million
Sustains Strong Balance Sheet with ~$185.3 million of Cash and Debt-Free Cannabis Business 2
EDMONTON, AB, June 18, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the fourth quarter and fiscal year 2025 periods ending March 31, 2025.
"We are pleased to report an exceptional year to our shareholders, highlighted by record annual global medical net revenue 1, adjusted EBITDA 1, and positive free cash flow 1. These achievements underscore the thoughtful execution of our strategic plan, set us further apart from competitors, and strengthen our foundation for sustained and profitable growth," said Executive Chairman and Chief Executive Officer for Aurora, Miguel Martin.
"Specific to Q4 2025, we ended our banner fiscal year by further strengthening our business model. International revenue more than doubled, representing 61% of global medical cannabis net revenue 1. Plant propagation also increased significantly as we benefited from peak seasonality along with organic expansion. These top-line gains were complemented by a sharp year over year increase in adjusted EBITDA 1 profitability and the third quarter of positive free cash flow 1 generation." concluded Mr. Martin.
_________________________________
1 This press release includes certain non-GAAP financial measures, which are intended to supplement, not substitute for, comparable GAAP financial measures. See "Non-GAAP Measures" below for reconciliations of non-GAAP financial measures to GAAP financial measures.
2 Aurora's only remaining debt is non-recourse debt of $61.7 million relating to Bevo Farms Ltd as detailed in the March 31, 2025 Financial Statements.
Fourth Quarter 2025 Highlights
(Unless otherwise stated, comparisons are made between fiscal Q4 2025, Q3 2025, and Q4 2024 results and are in Canadian dollars)
Consolidated Revenue and Adjusted Gross Profit:
Total net revenue 1 was $90.5 million, as compared to $67.4 million in the prior year period. The 34% increase from the prior year period was mainly due to 48% growth in our global medical cannabis business and 32% growth in our plant propagation business, slightly offset by lower quarterly revenue in our consumer cannabis business.
Consolidated adjusted gross margin before fair value adjustments 1 was 62% in Q4 2025 and 50% in the prior year period. Adjusted gross profit before FV adjustments 1 was $54.2 million in Q4 2025 compared to $33.4 million in the prior year period, an increase of 62%.
Medical Cannabis:
Medical cannabis net revenue 1 was $67.8 million, a 48% increase from the prior year period, delivering 75% of Aurora's Q4 2025 consolidated net revenue 1 and 88% of adjusted gross profit before fair value adjustments 1.
The increase in medical cannabis net revenue 1 of $22.1 million was primarily due to higher sales to Australia, Germany, Poland, and the UK, as well as increased revenue in Canada to insurance covered and self-paying patients.
Adjusted gross margin before fair value adjustments 1 on medical cannabis net revenue 1 reached 70% for the three months ended March 31, 2025, compared to 66% in the prior year period. The adjusted gross margins before fair value adjustments 1 improved through sustainable cost reductions, higher selling prices, and improved efficiency in production operations, including sourcing for Europe from Canada.
Consumer Cannabis:
Aurora's consumer cannabis net revenue 1 was $8.2 million a 20% decrease compared to $10.2 million in the prior year period. The decrease was due to our continued decision to prioritize the supply of our GMP manufactured products to our high margin global medical cannabis business rather than the consumer business, which offers lower margins.
Adjusted gross margin before fair value adjustments 1 on consumer cannabis net revenue 1 was 27%, an increase from 16% compared to the prior year period. The increase from the prior year period is primarily due to cost improvements resulting from spend efficiencies.
Plant Propagation:
Plant propagation net revenue 1 was wholly comprised of the Bevo business, and contributed $13.8 million of net revenue 1, a 32% increase compared to $10.4 million in the prior year period. The increase was a result of organic growth and expanded product offerings, both arising from increased capacity.
Adjusted gross margin before fair value adjustments 1 on plant propagation revenue was 37% for Q4 2025 and 25% for the prior year period. The fluctuations in the plant propagation adjusted gross margin before fair value adjustments 1 is due to product mix with higher margin sales.
Adjusted Selling, General and Administrative ("Adjusted SG&A"):
Adjusted SG&A 1 was $36.7 million in Q4 2025, which excludes $5.8 million of business transformation costs. The increase compared to the prior year period relates to higher freight and logistics costs, notably from sales to Europe with the increase in sourcing from Canada and incremental costs following the acquisition of MedReleaf Australia.
Net Income (Loss):
Net loss from continuing operations for the three months ended March 31, 2025 was $17.2 million compared to a net loss of $20.3 million for the prior year period. The decrease in net loss of $3.0 million compared to the three months ended March 31, 2024 is comprised of a decrease in gross profit of $18.8 million and an increase in operating expenses of $3.0 million, offset with other income in the current period $10.5 million compared to other expenses of $18.7 million during the three months ended March 31, 2024.
Adjusted EBITDA:
Adjusted EBITDA 1 increased 619% to $16.7 million for the three months ended March 31, 2025 compared to $2.3 million for the prior year period.
Fiscal Q1 2026 Expectations:
Expect continued strong global cannabis revenue driven by improved performance in Canadian medical, comparable performance in consumer, offset by temporary declines in some of our international markets. Taken together, global cannabis should be slightly lower compared to Q4 2025 and is expected to improve in later quarters due to increased distribution and further innovation.
Seasonally higher revenues for plant propagation as they complete their peak quarter, in line with historical seasonal trends.
Margins to hold strong and we expect positive adjusted EBITDA 1 to continue, with a decline versus Q4 FY25 due to lower revenue contributions from the higher margin international markets.
Free cash flow 1 is projected to remain positive, due to continued strong performance and improved operating cash use.
Historical Quarterly Results:
In connection with the audit of the annual consolidated financial statements as at and for the year ended March 31, 2025, the Company identified an error in inventory and cost of sales arising from intercompany profit eliminations, resulting in an overstatement of inventory and understatement of cost of sales. Additionally, the Company understated its lease liability during a period in which a rent concession was granted by the lessor. In respect of the Company's presentation of cash and cash equivalents and restricted cash, the Company determined that certain previously reported restricted cash held within its captives was accessible to the Company and therefore not restricted. The unrestricted portion has been reclassified to cash and cash equivalents.
The Company has concluded that these errors are not material to any of the Company's previously-issued audited consolidated financial statements and unaudited condensed consolidated interim financial statements. Accordingly, the Company has concluded that an amendment to its previously-filed audited consolidated financial statements and unaudited condensed consolidated interim financial statements is not required. The revisions will be reflected in the comparative period of the Company's prospective condensed consolidated interim financial statements filings. There is no impact to the annual consolidated financial statements, however the comparative periods have been revised accordingly.
The core balances impacted in the consolidated financial position and cash flow are: cash and cash equivalents, restricted cash, inventory and property, plant and equipment. In the consolidated statement of income (loss) the core areas impacted are: cost of sales, gross profit and net income (loss).
A summary of the impact to its previously filed audited consolidated financial statements and unaudited condensed consolidated interim financial statements can be found in the historical quarterly results section of the FY25 Q4 MD&A, filed June 18, 2025 (the "MD&A").
Key Quarterly Financial Results
($ thousands, except Operational Results)
Three months ended
March 31, 2025
December 31, 2024 (4)
$ Change
% Change
March 31, 2024 (3)
$ Change
% Change
Financial Results
Net revenue (1a)
$90,538
$88,198
$2,340
3 %
$67,411
$23,127
34 %
Medical cannabis net revenue (1a)
$67,776
$68,149
($373)
(1 %)
$45,648
$22,128
48 %
Consumer cannabis net revenue (1a)
$8,166
$9,912
($1,746)
(18 %)
$10,233
($2,067)
(20 %)
Plant propagation revenue
$13,770
$8,897
$4,873
55 %
$10,416
$3,354
32 %
Adjusted gross margin before FV adjustments on total net
revenue (1b)
62 %
61 %
N/A
1 %
50 %
N/A
12 %
Adjusted gross margin before FV adjustments on cannabis
net revenue (1b)
65 %
63 %
N/A
2 %
54 %
N/A
11 %
Adjusted gross margin before FV adjustments on medical
cannabis net revenue (1b)
70 %
69 %
N/A
1 %
66 %
N/A
4 %
Adjusted gross margin before FV adjustments on
consumer cannabis net revenue (1b)
27 %
26 %
N/A
1 %
16 %
N/A
11 %
Adjusted gross margin before FV adjustments on plant
propagation net revenue (1b)
37 %
40 %
N/A
(3 %)
25 %
N/A
12 %
Adjusted SG&A expense (1d)
$36,687
$31,263
$5,424
17 %
$31,351
$5,336
17 %
Adjusted EBITDA (1c)
$16,678
$19,393
($2,715)
(14 %)
$2,319
$14,359
619 %
Free cash flow (1e)
$2,495
$27,364
($24,869)
(91 %)
($21,866)
$24,361
111 %
Balance Sheet
Working capital (1f)
$367,465
$338,741
$28,724
8 %
$301,985
$65,480
22 %
Cannabis inventory and biological assets (2)
$193,980
$212,075
($18,095)
(9 %)
$148,112
$45,868
31 %
Total assets
$852,666
$862,297
($9,631)
(1 %)
$838,673
$13,993
2 %
(1)
These terms are defined in the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of this MD&A. Refer to the following sections for reconciliation of Non-GAAP Measures to the IFRS equivalent measure:
a. Refer to the "Revenue" and "Cost of Sales and Gross Margin" section for a reconciliation of cannabis net revenue to the IFRS equivalent.
b. Refer to the "Adjusted Gross Margin" section for reconciliation to the IFRS equivalent.
c. Refer to the "Adjusted EBITDA" section for reconciliation to the IFRS equivalent.
d. Refer to the "Operating Expenses" section for reconciliation to the IFRS equivalent.
e. Refer to the "Liquidity and Capital Resources" section for a reconciliation to the IFRS equivalent.
f. "Working capital" is defined as Current Assets less Current Liabilities as reported on the Company's Consolidated Statements of Financial Position.
(2)
Represents total biological assets and inventory, exclusive of merchandise, accessories, supplies, consumables and plant propagation biological assets.
(3)
Certain previously reported amounts have been adjusted to exclude the results of discontinued operations.
(4)
In connection with the audit of the annual consolidated financial statements as at and for the year ended March 31, 2025, the Company noted that inventory and lease obligation were misstated, impacting the condensed consolidat interim statements filed during the 2025 fiscal year.Certain balances in the condensed consolidated interim financial statements as at and for the three months ended June 30, 2024, September 30, 2024 and December 31, 2024 were adjusted as a result and the amounts shown above reflect such adjustments. Refer to discussion under "Historical Quarterly Results" section of this MD&A for further detail.
Conference Call
Aurora will host a conference call today, Wednesday, June 18, 2025, to discuss these results. Miguel Martin, Chief Executive Officer, and Simona King, Chief Financial Officer, will host the call starting at 8:00 a.m. Eastern time | 6:00 a.m. Mountain Time. A question and answer session will follow management's presentation.
About Aurora Cannabis
Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on X and LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".
Forward Looking Statements
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law (" forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding ethe Company's Q4 and full year FY2025 results, statements under the heading "Fiscal Q1 2026 Expectation", including, but not limited to those related to revenue growth and adjusted gross margins, revenue in the plant propagation segment, and expectations for positive adjusted EBITDA and positive free cash flow, statements regarding the Company's continued commitment to strategic growth, operational excellence, and long-term sustained profitability, as well as statements regarding the Company's conference call to discuss results.
These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the magnitude and duration of potential new or increased tariffs imposed on goods imported from Canada into the United States, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations (with respect to the Transaction and more generally with respect to future acquisitions), management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information from dated June 17, 2025 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed with and available on the U.S Securities and Exchange Commision's EDGAR ("SEC")\ website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
The Company's annual consolidated financial statements, the MD&A and AIF are available as part of the Company's Annual Report on Form 40-F filed with the SEC and available under the Company's profile on the SEC's website. These documents are also available on the Company's website, www.auroramj.com, and shareholders may receive hard copies of such documents free of charge upon request.
Non-GAAP Measures
This news release contains reference to certain financial performance measures that are not recognized or defined under IFRS (termed "Non-GAAP Measures"). As a result, this data may not be comparable to data presented by other licensed producers of cannabis and cannabis companies. Non-GAAP Measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company's operating results, underlying performance and prospects in a manner similar to Aurora's management. Accordingly, these non-GAAP Measures are intended to provide additional information and to assist management and investors in assessing financial performance and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. The information included under the heading "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" in the MD&A is incorporated by reference into this news release. The MD&A is available on the Company's issuer profiles on SEDAR+ at www.sedarplus.com and on the SEC's EDGAR website at www.sec.gov.
Net Revenue, Adjusted Gross Profit and Margin
Net revenue, adjusted gross profit before FV adjustments, and adjusted gross margin before FV adjustments are Non-GAAP Measures and can be reconciled with revenue, gross profit and gross margin, the most directly comparable GAAP financial measures, respectively, as follows:
(1)
Net revenue is a Non-GAAP Measure and is defined in the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of this MD&A. Refer to the "Cost of Sales and Gross Margin" section of this MD&A for a reconciliation to IFRS equivalent.
(2)
Certain previously reported amounts have been adjusted to exclude the results related to discontinued operations.
Adjusted EBITDA
The following is the Company's adjusted EBITDA:
(1)
Business transformation related charges include costs related to closed facilities, certain IT project costs, costs associated with the repurposing of Sky and Sun, severance and retention costs in connection with the business transformation plan, and costs associated with the retention of certain medical aggregators. Some prior period amounts have been adjusted for changes in presentation.
(2)
Out-of-period adjustments reflect adjustments to net loss for the financial impact of transactions recorded in the current period that relate to prior periods. Some prior period amounts have been adjusted for changes in presentation.
(3)
Non-recurring items includes one-time excise tax refunds, non-core adjusted wholesale bulk margins, inventory count adjustments resulting from facility shutdowns and inter-site transfers, litigation and non-recurring project costs.
(4)
Adjusted EBITDA is a Non-GAAP Measure and is not a recognized, defined, or standardized measure under IFRS. Refer to "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of the MD&A. Prior period comparatives were adjusted to include the adjustments for markets under development, business transformation costs and non-recurring charges related to non-core bulk cannabis wholesale to be comparable to the current period presentation.
(5)
Certain previously reported amounts have been adjusted to exclude the results of discontinued operations.
(6)
In connection with the audit of the annual consolidated financial statements as at and for the year ended March 31, 2025, the Company noted that inventory and lease obligation were misstated, impacting the condensed consolidated interim statements filed during the 2025 fiscal year. Certain balances in the condensed consolidated interim financial statements as at and for the three months ended June 30, 2024, September 30, 2024 and December 31, 2024 were adjusted as a result and the amounts shown above reflect such adjustments. Refer to discussion under "Historical Quarterly Results" section of this MD&A for further detail.
Adjusted SG&A
Adjusted SG&A is a Non-GAAP Measure and can be reconciled with sales and marketing and general and administrative expenses, the most directly comparable GAAP financial measure, as follows:
(1)
Adjusted SG&A is a Non-GAAP Measure and is not a recognized, defined, or standardized measure under IFRS. Refer to the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of this MD&A.
(2)
Certain previously reported amounts have been adjusted to exclude the results of discontinued operations.
(3)
In connection with the audit of the annual consolidated financial statements as at and for the year ended March 31, 2025, the Company noted that inventory and lease obligation were misstated, impacting the condensed consolidated interim statements filed during the 2025 fiscal year. Certain balances in the condensed consolidated interim financial statements as at and for the three months ended June 30, 2024, September 30, 2024 and December 31, 2024 were adjusted as a result and the amounts shown above reflect such adjustments. Refer to discussion under "Historical Quarterly Results" section of this MD&A for further detail.
Free Cash Flow
The table below outlines free cash flow for the periods ended:
(1)
Maintenance capital expenditures are comprised of costs to sustain facilities, machinery and equipment in working order to support operations and excludes discretionary investments for revenue growth.
(2)
Free cash flow is a Non-GAAP Measure and is not a recognized, defined, or a standardized measure under IFRS. Refer to the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of this MD&A.
(3)
Certain previously reported amounts have been adjusted for a reclassification of restricted cash to cash and cash equivalents as at March 31, 2024, June, 30, 2024, September 30, 2024 and December 31, 2024. Refer to discussion under "Historical Quarterly Results" section of the MD&A for further detail.
Working Capital
Working capital is a Non-GAAP Measure and can be reconciled with total current assets and total current liabilities, the most directly comparable GAAP financial measure, as follows:
Three months ended
($ thousands)
March 31, 2025
December 31,
2024
March 31, 2024
Total current assets
478,328
488,548
426,605
Total current liabilities
(110,863)
(149,807)
(124,620)
Working capital (1)
367,465
338,741
301,985
(1)
Working capital for the three months ended December 31, 2024 has been adjusted. Refer to discussion under "Liquidity and Capital Resources" section of the MD&A.
SOURCE Aurora Cannabis Inc.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
38 minutes ago
- Cision Canada
Statement by Minister Valdez to mark National Indigenous Peoples Day Français
OTTAWA, ON, /CNW/ - The Honourable Rechie Valdez, Minister of Women and Gender Equality and Secretary of State (Small Business and Tourism), made the following statement: "Today, I join communities across the country in celebrating National Indigenous Peoples Day. "This is a time to honour the rich histories, vibrant cultures and enduring contributions of First Nations, Inuit, and Métis. From coast to coast to coast, we celebrate the strength, resilience, and leadership of Indigenous communities. "Today, more than 50,000 small businesses are majority-owned by Indigenous entrepreneurs. Indigenous-led businesses are fuelling economic growth and uplifting communities across the country. "In 2023 alone, Indigenous tourism operators generated an estimated 34,700 jobs and billions of dollars in economic activity. These numbers tell a powerful story of resilience and innovation and highlight the vital role Indigenous businesses play in our tourism economy. "As Minister of Women and Gender Equality, I am committed to supporting Indigenous-led efforts to end gender-based violence. Through the National Action Plan to End Gender-Based Violence and the Federal Pathway to Address Missing and Murdered Indigenous Women, Girls and 2SLGBTQQIA+ Peoples, our government is working in partnership with First Nations, Inuit and Métis communities to develop policies and fund programs to end the national crisis facing Indigenous women, girls and 2SLGBTQQIA+ people. This work is essential to healing, justice and safety for Indigenous women, girls and 2SLGBTQQIA+ people, wherever they live. "Our government is deeply committed to advancing reconciliation and to building lasting partnerships with Indigenous Peoples by supporting entrepreneurs, fostering economic opportunity and building an inclusive economy that leaves no one behind. Stay connected Follow the department on . For easy access to government programs for businesses, download the Canada Business app.
Globe and Mail
an hour ago
- Globe and Mail
If Canada is seeking an ideal nation-building project, it should invest in First Nations infrastructure
Cindy Woodhouse Nepinak is national chief of the Assembly of First Nations. At a time of growing global uncertainty – amid trade disruptions, rising inflation, climate change and international instability – Canada is looking for ways to strengthen its economy, create good jobs and build lasting resilience. Investing in First Nations infrastructure directly supports these national priorities and represents one of our greatest collective nation-building opportunities. Every person in Canada deserves clean water to drink, reliable infrastructure to support their families and a strong foundation to build a future. Yet for far too many First Nations, these basic needs remain out of reach owing to generations of underinvestment. According to the Assembly of First Nations' report "Closing the Infrastructure Gap," an estimated $349.2-billion is needed to bring First Nations infrastructure in line with the rest of Canada by 2030. Delays would only increase the cost and limit the potential returns. And there would be significant returns. Additional research, supported by the Conference Board of Canada, shows that improving First Nations infrastructure would generate $635-billion in economic output, boost GDP by $308.9-billion, and create 330,000 jobs annually across Canada over seven years. Prime Minister Mark Carney has even acknowledged the 'potential economic opportunity' of closing the infrastructure gap. On the campaign trail, Mr. Carney argued that doing so would, on its own, have a larger positive impact on Canada's economy than the negative effects of Donald Trump's tariffs, underscoring both the urgency and the scale of this opportunity. New federal legislation would cut internal trade barriers, advance 'nation-building' projects Beyond the economic data, these investments would also mean that children could sleep safely in their own homes, enjoy clean water in every community, use reliable transportation to access high-quality healthcare and education services, and take advantage of connectivity that allows young people to fully participate in Canada's economy. This would be nation-building in the fullest sense. First Nations are not waiting. Across the country, First Nations are already leading major nation-building projects, from the Clear Sky Connections broadband project linking 63 Manitoba First Nations, to new water systems in Listuguj Mi'gmaq territory, to the Squamish Nation's Sen̓áḵw housing project in Vancouver. These projects meet urgent needs while driving growth, clean energy, and digital connectivity that benefit the entire country. They show what's possible when communities have the resources to build. But to fully close the infrastructure gap nationwide, sustained federal investment is essential. Opinion: Canada needs to attract private investment in infrastructure – and Indigenous communities hold the key As governments put forward legislative proposals to advance major infrastructure projects, proposals that come at the expense of First Nations rights are not the path forward. Any development must respect inherent and treaty rights as recognized and affirmed by the Constitution, and must reflect the Crown's duty to consult and obtain free, prior, and informed consent, as affirmed in the United Nations Declaration on the Rights of Indigenous Peoples Act. Today marks National Indigenous Peoples Day and the four-year anniversary of the United Nations Declaration on the Rights of Indigenous Peoples Act. Yet instead of advancing reconciliation, Canada is pushing legislation like Bill C-5 without hearing from First Nations rights holders. At this week's AFN National Virtual Forum, leaders raised serious concerns about the bill's impact on First Nations rights. Chiefs called for that same urgency to be directed toward the infrastructure our communities actually need – homes, schools, clean water, roads and internet. Chartrand on Bill C-5: 'We do have to have consent from Indigenous rights holders' Fast-tracking development while sidelining rights-holders doesn't advance reconciliation – it undermines it. Attempts to override rights and exclude First Nations from decision-making reflect a narrow and incomplete vision of nation-building, and risk sidelining one of Canada's most transformative opportunities for shared prosperity. The path forward is not to build first and address rights later. True national interest requires full participation and consent of First Nations rights-holders from the start. Canada must prioritize sustained investments in First Nations-led infrastructure that strengthen community resilience and contribute directly to Canada's economic, climate and long-term sustainability priorities. By any measure, investments in First Nations infrastructure meet the definition of national interest. The government's own proposed framework includes priorities like economic growth, resilience and clean growth, all of which would be directly advanced by such investments. If Canada is serious about building a stronger, more secure and more prosperous future, let's start with fast-tracking the construction of new homes, modern schools and clean water systems in First Nation communities. Let's fast-track internet access, all-season roads and community infrastructure that has long been neglected. Let's work in true partnership, through full consultation, shared legislative development, and recognition that Canada's future is tied to the success of its First Peoples. That is how you build a country – by ensuring the foundations are strong for everyone. The future of Canada depends on it.
CBC
an hour ago
- CBC
Vancouver company celebrates reusable food container success
Social Sharing While there are multiple ways to eschew single-use food takeout containers in favour of reusable ones, a Vancouver company says it has moving toward being a major player in the sector. was founded in 2021 by Jason Hawkins and Anastasia Kiku, then both in their mid-20s, as a way to address the scourge of single-use takeout containers they were seeing piling up in garbage cans, landfills — or even worse — as litter. "We just don't have any more time to sit and not do something," said Kiku at the time about their concept. The company provides businesses with reusable containers, which are given to customers at checkout without a deposit. Customers are only charged — between $5 and $10 — if the containers aren't returned to special bins that track them. It's a simple concept, which others are also doing, but comes with hurdles such as getting customers to change their habits to adopt the system. says the company recognized its system, now at places such as University of Victoria and Simon Fraser University, is a good fit for where consumers, such as students and staff, return to the same place over and over again. "It really makes sense as a perfect closed-loop model where everyone is in that location," said Jasper Law, the company's product lead. "It's easy for them to know that they can bring it back to that place." Reusables also has improved its made-in-Vancouver return bins. Users scan their container to open the bin, meaning it's tamper-proof and can only be filled with Reusables containers. Law said a successful reusable-container business has to have a high rate of return to be viable. "What matters in these programs is return rate," he said. "So we are striving to get as close to 100 per cent as possible because every container loss needs to be replaced and that eliminates the value of the program." West Vancouver's Hollyburn Country Club is now using the system for its 8,000 members. Officials say member often received food or drink in single-use containers, but used them and discarded them on site, which created a garbage problem. "So we thought we should look for an alternative solution," said Caitlin Lundy, the club's director of sales and communication. The club says it's now saving between 8,000 and 10,000 units of paper cups, plastic lids and paper takeout containers per month. "So the initial cost of the system, it paid for itself within about two months," Lundy said. Company receives seed funding captured nearly $4 million in seed funding in April to help it expand further. "We're thrilled to be backed by the best tech and climate investors as we scale real impact, not just optics," said Hawkins in a release from the company. "Greenwashing won't solve the waste crisis — technology and execution will." Single-use item waste is a big problem to tackle in a "take, make waste society," said Denise Philippe, Metro Vancouver's National Zero Waste Council's senior policy adviser. Metro Vancouver has ambitious goals to reduce this type of waste and commended companies like for trying to make a difference. "I think there's lots of creativity and innovation that's happening in this space," said Philippe. "So kudos to both the reuse systems [and] system providers that are out there … scratching their heads … and trying to figure out how to make this work and make it work at scale and make it cost efficient."
